QA: Aravive Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2023_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 57,970,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 270,000
3 remainder_Assets 3,913,000
4 LiabilitiesCurrent 22,112,000
5 LiabilitiesNoncurrent 2,503,000
6 remainder_Liabilities 26,881,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,345,419
9 ResearchAndDevelopmentExpense 87,874,345
10 remainder_Expenses 5,486
11 remainder_Revenues 8,518,590
12 remainder_NetIncome 2,844,475
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 62,153,000
1 Liabilities 51,496,000
2 Expenses 102,225,250
3 Revenues 8,518,590
4 StockholdersEquity 10,657,000
5 NetIncome -90,862,185
6 ComprehensiveNetIncome -90,862,185
7 BaseVar 113,618,658
8 EconomicCapitalRatiobeforeLimitedLiability -1.19
9 EconomicCapitalRatio 1.26

Edgar->Model Mapping

Feature Distribution

Change over Time